Open access peer-reviewed chapter

Thyroidectomy without Ligatures in Differentiated Thyroid Cancer

By Molnar Călin, Butiurca Vlad Olimpiu, Molnar Varlam Claudiu and Botoncea Marian

Submitted: February 25th 2018Reviewed: June 23rd 2018Published: November 5th 2018

DOI: 10.5772/intechopen.79730

Downloaded: 384

Abstract

Technical improvements in thyroid surgery are nearly close with the progress of the vessels sealing systems. In all cases, we need to obtain a radical and safe thyroid excision. This chapter is conducted to evaluate the technical key point and the postoperative benefits of our procedure using vessels sealing devices in differentiated thyroid cancers. A prospective study, carried out in First Surgical Clinic, Emergency County Clinical Hospital Tirgu Mureș, Romania from January 01, 2013 to March 01, 2018, based on 100 consecutive patients, divided into two groups: first group without ligatures, using Small Jaw LigaSure™, and the second group operated by conventional procedure. Statistical analysis of some parameters (the thyroid pathology, operative time, hospitalization days, analgesic drugs, immediate postoperative complications and histopathological findings) shows that this procedure provides a total and “complete” removal of the thyroid specimen, with a decreased operative time and fewer hospitalization days.

Keywords

  • thyroid cancer
  • LigaSure™ small jaw
  • vessel sealing device

1. Introduction

Thyroid cancer represents approximately 3.8% of all new cancer cases having different genetics, histogenesis and evolution, requiring specific management protocols and consensus [1]. Although a diagnosis of cancer is frightening, the vast majority of thyroid cancers is highly treatable and in most cases curable with a multidisciplinary treatment in which surgery plays an important role.

In this chapter, we present the technical key points and postoperative benefits of the procedure, using LigaSure™ small jaw in differentiated thyroid cancer.

2. Short history of thyroidectomy

During the twelfth and thirteenth century, there were many speculations regarding the role and the function of the thyroid gland and surgeries have been done according to them [2]. Roger Frugardi was first, in 1170, to describe the extirpation of the gland using setons, hot irons and caustic powder [3].

Evolution of thyroidectomy is related to the advances of the technology even though in the nineteenth century this procedure was considered “barbaric horrid butchery” (by S. Gross) [4]. Later on, in 1880, Jules Boeckel of Strasbourg introduced the collar incision to thyroid surgery, and this approach was popularized, later on, by Theodor Kocher.

The thyroidectomy (near or total), as we know it today, began in the 1860s with the help of Billroth [5]. Thyroid surgery was undertaken before the physiology was understood leading to complications, including massive hemorrhage, infection or injuries of the surrounding structures, which were associated with morbidity and mortality rates of about 40% [4].

In 1880, Sandstrom discovered the parathyroid glands but the fact that hypocalcemia was the definitive cause of tetany was not accepted until the twentieth century [6].

Later, in the nineteenth and the beginning of the twentieth centuries, Theodor Kocher practiced a meticulous thyroidectomy being able to report a mortality rate of 1%. He also described the “cachexia strumipriva” in patients following total thyroidectomy. For his contribution to thyroid pathology, Kocher received the Nobel Prize in 1909 [7, 8].

In 1920, the advances in thyroidectomy reached the peak making Halsted to refer to this surgery as a “feat which today can be accomplished by any competent operator without danger of mishap” [1].

Nowadays, thyroid surgery can be performed with a low mortality as well as with low morbidity. In order to obtain such results, surgeon must be aware of the pathophysiology of the thyroid disorders and must know very well the cervical anatomy.

3. Differentiated thyroid cancer

According to the American Cancer Society, differentiated thyroid cancer (DTC) derives from thyrocytes and expresses the sodium iodine symporter. DTC includes papillary, follicular and Hurthle cell cancer and represents most of thyroid cancer (90%).

3.1. Papillary cancer

About 80% of the patients diagnosed with thyroid cancers present the form of papillary carcinoma. This form of papillary cancer develops slowly, and it usually affects only one thyroid lobe. With a slow growth, the papillary cancers often spread to the locally lymph nodes. Even it also affects the local lymph nodes, this cancer responds well to the treatment and is rarely fatal. There are several subtypes of papillary cancers, more than 10 histological variants which are documented and can be seen in Table 1 [9, 10].

Papillary thyroid cancerVariants
Classic (usual)
Clear cell
Columnar cell
Cribriform-morular
Diffuse sclerosing
Follicular
Macrofollicular
Microcarcinoma (occult, latent, small, microtumor)
Solid
Tall cell
Warthin-like

Table 1.

Variants of papillary thyroid cancer.

3.2. Follicular cancer

Unlike the papillary form, the follicular cancer is the second most common thyroid cancer, affecting 10% of the persons diagnosed with thyroid cancer. It is more common in patients whose diet is poor in iodine. This type of cancer is characterized by the development of distant metastases, affecting organs such as the lungs and bones. The prognosis of this type of cancer varies depending on the degree of invasiveness. In the traditional classification of follicular thyroid cancer (FTC), there are two groups: minimally invasive and widely invasive [11, 12, 13].

3.3. Hurthle cell cancer

This type is also known as oxyphil cell carcinoma. About 3% of thyroid cancers are of this type. Most of the authors consider it as a form of follicular cancer [14].

4. Risk classification of DTC

The risk classification helps to predict the risk of local recurrence and developing metastases and the mortality in patients with DTC. It uses multiple staging systems which are based on a combination of the size of the primary tumor, specific histology, extrathyroidal spread of the tumor and the age at diagnosis.

The staging system most often used for thyroid cancer is the TNM (Table 2) system, which is based on three key pieces of information:

  • T = the size of the tumor

  • N = the spread to the nearby lymph nodes

  • M = the spread to distant sites (metastasis)

TX: Primary tumor cannot be evaluated
T0: There is no evidence of primary tumor
T1: Tumor limited to the thyroid, whose maximum dimension does not exceed 2 cm
T1a: Tumor limited to the thyroid, whose greatest dimension does not exceed 1 cm
T1b: Tumor limited to the thyroid gland with dimension >1 cm, but lower than 2 cm in greatest dimension
T2: Tumor >2 cm but ≤4 cm in greatest dimension limited to the thyroid
T3: Tumor limited to the thyroid or with minimal extrathyroidal extension, with dimension <4 cm
T3a: Tumor dimension >4 cm but is limited to the thyroid
T3b: Minimal extrathyroidal extension invading the strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) from a tumor of any size
T4: Includes extrathyroidal extension into neck major structures
T4a: Tumor of any size with extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve
T4b: Tumor of any size with extrathyroidal extension invading prevertebral fascia or encasing carotid artery or mediastinal vessels
NX: Regional lymph nodes cannot be evaluated
N0: There is no evidence of regional lymph node metastasis
N1: Metastasis to regional nodes
N1a: Unilateral or bilateral disease involving level VI or VII lymph nodes metastasis (pretracheal, paratracheal, prelaryngeal / Delphian or upper mediastinal)
N1b: Unilateral, bilateral or contralateral lymph nodes metastasis (levels I, II, III, IV or V) or retropharyngeal lymph nodes
M0: No distant metastasis
M1: Distant metastasis

Table 2.

TNM classification, 8th edition [15].

The most common risk classification is based on the tumor node metastasis (TNM) classification:

  • very low-risk group: pT1a, cN0/pN0, cM02;

  • low-risk group: pT1b, pT2, cN0/pN0, cM0;

  • high-risk group: pT3, pT4, each N1, all M1.

Based on the risk of structural disease recurrence, the American Thyroid Association defines in their current guideline the next classification [16]:

  • high-risk group: gross extrathyroidal extension, incomplete tumor resection, distant metastases, or lymph node >3 cm;

  • intermediate-risk group: aggressive histology, minor extrathyroidal extension, vascular invasion, or >5 involved lymph nodes (0.2–3 cm);

  • low-risk group: intrathyroidal DTC, ≤5 lymph nodes micrometastases (<0.2 cm)

The American Joint Committee on Cancer (AJCC) uses the combination of TNM classification and an age of more than 55 years at diagnosis as risk factor (Table 3).

Age at diagnosis <55 years
Stage I:any Tany NM0
Stage II:any Tany NM1
Age at diagnosis ≥55 years
Stage I:T1N0/NXM0
T2N0/NXM0
Stage II:T1N1M0
T2N1M0
T3a/T3bany NM0
Stage III:T4aany NM0
Stage IVA:T4bany NM0
Stage IVB:any Tany NM1

Table 3.

Stage grouping according to AJCC.

5. Surgery without ligatures

Total complete thyroidectomy is the procedure that can be defined as an extracapsular thyroidectomy in which we remove the entire gland without remnant tissue.

5.1. Surgical instruments

The tool kit consists of a scalpel, Pean forceps (1–2 pieces), anatomical and surgical forceps, scissors, Farabeuf or Kocher spacers, monopolar cautery and LigaSure™ small jaw.

5.2. Incision

A 5–6 cm Kocher incision is performed in a flexion fold at 2–2.5 cm of the sternal notch. The skin, the subcutaneous cellular tissue and the platysma muscle are cut, after which a superior and a lower flap is made by dissection using LigaSure™ or electrocautery. The upper flap is suspended, exposing the white line (Figures 13).

Figure 1.

Kocher incision.

Figure 2.

Preparing the upper and lower flap.

Figure 3.

Suspending the upper flap.

5.3. How we do it

Penetration into the cleavage space by cutting the medial raf and releasing the anterior face of the anterior thyroide lobe. The thyroid lobe is mobilized with a thread (Figure 4).The dissection is continued laterally by sealing the middle thyroid vein with the LigaSure™ small jaw, then continuing cranially to the upper thyroid at the same time as the thyroid lobe dislocates (Figure 5).

Figure 4.

Traction of the thyroid lobe using thread.

Figure 5.

Lateral dissection with the sealing of the medial vein.

Upper pole dissection with LigaSureSmall Jaw, sealing the upper thyroid vascular pedicle (Figure 6).

Figure 6.

Sealing the upper thyroid pedicle.

The sealing of the lower branches of the lower thyroid pedicle is the essential time of this intervention, with the preservation of parathyroids, secondary branches of the inferior artery and the recurrent nerve. Dissection proceeds to the median line, sectioning Berry’s ligaments.

Lobectomy ends with the separation of the isthmus, being an optional time, or we can achieve a monobloc resection of the gland (Figure 7).

Figure 7.

Monobloc resection of the thyroid gland.

Control of the hemostasis, drainage of the thyroid cavity, intradermal resorbable suture.

6. Evaluation of the technique

6.1. Study description

In order to evaluate the feasibility of the technique, we conducted a prospective study which was carried out in Clinic of Surgery I, Emergency Clinical County Hospital Târgu Mureș from January 01, 2013 to June 01, 2017. The study enrolled 100 consecutive patients divided into two lots: 50 who underwent total complete thyroidectomy using LigaSure™ small jaw, including 10 with “monobloc resection” and 50 in whom total thyroidectomy was performed by conventional procedure (by using ligatures). The two groups were compared using statistical analysis following the next parameters: the thyroid pathology, operative time, hospitalization days, analgesia used and immediate postoperative complications. Statistical analysis was performed employing Student’s test for comparison of the continuous variables. Differences between nonparametrical variables were compared using the Mann-Whitney U-test. Descriptive data were reported as the mean ± SD. The level of significance was set at p < 0.05.

All patients have been prior diagnosed by fine needle aspiration (FNA) biopsy showing either papillary or follicular cancer.

All patients had preoperative and postoperative endocrinological consultations, and all the female patients had gynecological examination prior to the surgery.

6.2. Results

Extracapsular thyroidectomy was performed in all patients.

Surgery consisted of performing total thyroidectomy and double drainage of the thyroid compartment.

The two groups included in this study had similar demographics (age, sex) and the thyroid pathology also being the same (Table 4).

Group 1Group 2
Mean age5452
Sex ratio F:M45:543:7

Table 4.

Patient’s demographic characteristics.

In the evaluation of the operative time measured from the moment of the skin incision to wound closure, we have found that statistical data followed a Gaussian distribution and it could be interpreted by Student’s t-test. The mean operative time in group 1 was 73.81 ± 16.96 min, which is significantly less than the operative time in the second group (conventional) 106.19 ± 31.66 min (Table 5).

Minimum4565
Mean73.81106.19
Maximum120200
Median72.5100
Standard deviation16.9631.66

Table 5.

Distribution of patients depending to the operative time.

To appreciate the length of hospital stay, we applied the nonparametric Mann-Whitney test, since the two groups did not have a Gaussian distribution pattern, because of the value of 17 days in group 1 and of 19 days in group 2. For group 1, the mean hospitalization time was of 4 days (range: 2–17 days), and for group 2, it was also 4 days (range: 3–19 days) (Table 6). We have not found statistically significant differences relating to these parameters of the patients in the two groups, regardless of the statistic method applied.

Group 1Group 2
Minimum22
Mean4.094.61
Maximum17.0019.00
Median3.004.00
Standard deviation2.953.21

Table 6.

Distribution of patients depending on length of hospitalization.

The evaluation of postoperative analgesia was performed by measuring the dose of analgesic drugs administered to each patient. The nonparametric Mann-Whitney test had been applied considering that the two groups did not have a Gaussian distribution (because of a maximal value of 17 days observed in the LigaSure-group and a maximal value of 19 days identified in the conventional group). The mean period of analgesia in group 1 was 2.5 days (range 1–16 days), while in group 2, it was 3 days (range: 2–19 days). There was no statistically significant difference between the period of analgesic drug requirement in the two groups (p = 0.06).

No patients developed manifestations of hypocalcemia (hypoparathyroidism). There were few patients who experienced a change in voice (low pitched voice) seen in three patients from group 1 and in four patients in group 2. Hematoma was observed in two patients belonging to group 1 and in four patients belonging to group 2. There is no statistic significant difference between the incidence of early postoperative complications in the two groups (Table 7).

Group 1Group 2
Low pitched voice34
Haematoma24

Table 7.

Complications in the two groups.

7. Discussion

Recently, thyroid surgery is considered quite safe, thanks to the proper surgical techniques that kept complications at a minimum rate (2–3%) [17].

The introduction of the new sealing devices in thyroid surgery benefits both patients and the surgeons. LigaSure™ small jaw is a proper device used to perform total complete thyroidectomy, and it gives some technical advantages like: creates a clean surgical field providing better visibility, observed in other study [18]; no need to expose the vascular pedicles their dissection being possible using the device’s forceps; reduces the operative time, also observed by Gac, Cabane and Hou Shan Yao [19, 20]; performs safe sealing of blood vessels, observed also by Marazzo and Lepner [20, 21]. This device can also remove the complications regarding the thread pathology.

The extracapsular total complete thyroidectomy can be performed without isthmectomy.

Dissection of vascular pedicles is relatively easy, allowing sufficient exposure to a very narrow anatomical space, and the separation and preservation of the integrity of the laryngeal nerves and parathyroid glands are possible in the absence of invasion by the pathological process (tumor or inflammatory).

By lower temperature dispersion (1–2 mm) from the device’s jaws, the nerve elements are spared, detaching the thyroid by cutting the Berry ligaments and avoiding burns in the laryngeal tracheal conduit.

In order to avoid the possible thyroidectomy complications such as parathyroid trauma or laryngeal nerves injuries, a good hemostasis becomes the priority for the thyroid surgeons. Hemostasis achieved by classic methods such as tie and clamp, electrocautery, clips is time consuming and can lead to knot slipping and thermal trauma of the surrounding tissues [22].

Nowadays, minimally invasive surgical techniques are used on a large scale in other surgical fields but thyroid gland resections, for both benign and malignant tumors are rarely performed. Zorron et al. described an endoscopic approach in patients without preexisting neck operations using transoral-vestibular approach but with the limitation of the study due to the need of the evaluation of the technique [23].

8. Conclusion

Total and “complete” thyroidectomy represents a feasible technique in our days.

In our opinion, based on the results, this technique can be considered safe.

Using the vessel sealing devices brings real benefits both for patients and surgeons.

In surgical services that do not have assisted video surgery, this technique can be considered ”gold standard” in selected cases.

Acknowledgments

Publications of this chapter has been funded by the “Toma Ionescu” Foundation, Gheorghe Marinescu Street no. 50, Targu-Mures, Romania.

Conflict of interest

There is nothing to declare.

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Molnar Călin, Butiurca Vlad Olimpiu, Molnar Varlam Claudiu and Botoncea Marian (November 5th 2018). Thyroidectomy without Ligatures in Differentiated Thyroid Cancer, Cancer Survivorship, Dil Afroze, IntechOpen, DOI: 10.5772/intechopen.79730. Available from:

chapter statistics

384total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Quality of Life Following Intersphincteric Resections for Low Rectal Cancer: Early Results

By Călin Molnar, Marian Botoncea, Claudiu Varlam Molnar and Vlad-Olimpiu Butiurca

Related Book

First chapter

Cell Cycle and Factors Involved in Inhibition or Progression of Breast Cancer

By Shazia Ali, Mohd Ishaq Dar, Rafiq A. Rather and Dil Afroze

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us